<DOC>
	<DOCNO>NCT00000478</DOCNO>
	<brief_summary>To assess feasibility test methodology full-scale clinical trial therapy asymptomatic cardiac ischemia .</brief_summary>
	<brief_title>Asymptomatic Cardiac Ischemia Pilot ( ACIP ) Study</brief_title>
	<detailed_description>BACKGROUND : Asymptomatic cardiac ischemia , frequently designate silent myocardial ischemia , refers episodes objectively demonstrable transient ischemia absence symptom . Annually , one million patient suffer acute myocardial infarction . Of approximately 700,000 discharge alive hospital , many 180,000 asymptomatic evidence myocardial ischemia pre-discharge exercise test . Asymptomatic ischemia link sudden death myocardial infarction . It estimate United States six million patient chronic , symptomatic coronary heart disease three million may exhibit transient asymptomatic myocardial ischemia . Asymptomatic ischemia think present majority coronary heart disease patient stable angina pectoris , 70 percent ischemic episode asymptomatic . Asymptomatic ischemia follow myocardial infarction presence chronic stable angina may associate substantially increase morbidity mortality Traditionally , treatment patient coronary heart disease give guide patient ' symptom . There grow trend toward recognize asymptomatic cardiac ischemia accord importance equal symptomatic ischemia . Many physician believe suppression asymptomatic ischemia patient coronary heart disease would reduce morbidity mortality . This lead rapidly increase widespread application medical revascularization therapy . In 1989 , lack knowledge relative efficacy different treatment strategy control asymptomatic cardiac ischemia . Given estimated high prevalence asymptomatic cardiac ischemia patient coronary heart disease evidence increase risk untoward outcome , public health problem sufficient magnitude warrant pilot study determine extent asymptomatic ischemia could control . If pilot study demonstrate feasibility , full-scale clinical trial would consider evaluate impact effective treatment asymptomatic ischemia survival cardiovascular morbidity patient coronary heart disease . DESIGN NARRATIVE : A total 1,959 patient screen AECG monitoring ; 49 percent asymptomatic ischemia , 65 percent enrol study . The 618 patient randomize one three treatment strategy : 202 angina-guided medical strategy titration anti-ischemic medication relieve angina ; 202 angina-guided plus AECG ischemia-guided medical strategy titration anti-ischemic medication eliminate angina AECG ischemia ; 212 revascularization angioplasty bypass surgery . Patients able take either beta-adrenergic blocking agent calcium antagonist also randomize receive one two medical combination regimen : atenolol plus nifedipine diltiazem plus isosorbide dinitrate . Those could treat one regimen , asthmatic patient , assign appropriate regimen . The primary outcome absence ischemia twelve week . Recruitment end January 1993 . Clinical base follow-up complete 18 month survival status free MI complete 24 month</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Nifedipine</mesh_term>
	<mesh_term>Diltiazem</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<criteria>Men aand woman angiographically document coronary artery disease , ischemia stress ( exercise ) test 48hour ambulatory electrocardiogram monitoring , amenable revascularization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2002</verification_date>
</DOC>